These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 26061183)

  • 41. A glyco-engineering approach for site-specific conjugation to Fab glycans.
    Jaramillo ML; Sulea T; Durocher Y; Acchione M; Schur MJ; Robotham A; Kelly JF; Goneau MF; Robert A; Cepero-Donates Y; Gilbert M
    MAbs; 2023; 15(1):2149057. PubMed ID: 36447399
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antibody-drug conjugates: the chemistry behind empowering antibodies to fight cancer.
    Drachman JG; Senter PD
    Hematology Am Soc Hematol Educ Program; 2013; 2013():306-10. PubMed ID: 24319196
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Polar Sulfamide Spacer Significantly Enhances the Manufacturability, Stability, and Therapeutic Index of Antibody-Drug Conjugates.
    Verkade JMM; Wijdeven MA; Van Geel R; Janssen BMG; Van Berkel SS; Van Delft FL
    Antibodies (Basel); 2018 Feb; 7(1):. PubMed ID: 31544864
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Glycan-Mediated Technology for Obtaining Homogeneous Site-Specific Conjugated Antibody-Drug Conjugates: Synthesis and Analytical Characterization by Using Complementary Middle-up LC/HRMS Analysis.
    Duivelshof BL; Deslignière E; Hernandez-Alba O; Ehkirch A; Toftevall H; Sjögren J; Cianferani S; Beck A; Guillarme D; D'Atri V
    Anal Chem; 2020 Jun; 92(12):8170-8177. PubMed ID: 32407621
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structural characterization of the maytansinoid-monoclonal antibody immunoconjugate, huN901-DM1, by mass spectrometry.
    Wang L; Amphlett G; Blättler WA; Lambert JM; Zhang W
    Protein Sci; 2005 Sep; 14(9):2436-46. PubMed ID: 16081651
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development of Solid-Phase Site-Specific Conjugation and Its Application toward Generation of Dual Labeled Antibody and Fab Drug Conjugates.
    Puthenveetil S; Musto S; Loganzo F; Tumey LN; O'Donnell CJ; Graziani E
    Bioconjug Chem; 2016 Apr; 27(4):1030-9. PubMed ID: 26942771
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of Fluorophore-Labeled Thailanstatin Antibody-Drug Conjugates for Cellular Trafficking Studies.
    Kulkarni C; Finley JE; Bessire AJ; Zhong X; Musto S; Graziani EI
    Bioconjug Chem; 2017 Apr; 28(4):1041-1047. PubMed ID: 28191936
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transglutaminase-Mediated Conjugations.
    Anami Y; Tsuchikama K
    Methods Mol Biol; 2020; 2078():71-82. PubMed ID: 31643050
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of Payload Hydrophobicity on the Stability of Antibody-Drug Conjugates.
    Buecheler JW; Winzer M; Tonillo J; Weber C; Gieseler H
    Mol Pharm; 2018 Jul; 15(7):2656-2664. PubMed ID: 29809017
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Platinum(II) as bifunctional linker in antibody-drug conjugate formation: coupling of a 4-nitrobenzo-2-oxa-1,3-diazole fluorophore to trastuzumab as a model.
    Waalboer DC; Muns JA; Sijbrandi NJ; Schasfoort RB; Haselberg R; Somsen GW; Houthoff HJ; van Dongen GA
    ChemMedChem; 2015 May; 10(5):797-803. PubMed ID: 25809281
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Control of recombinant monoclonal antibody effector functions by Fc N-glycan remodeling in vitro.
    Hodoniczky J; Zheng YZ; James DC
    Biotechnol Prog; 2005; 21(6):1644-52. PubMed ID: 16321047
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Statistical modeling of the drug load distribution on trastuzumab emtansine (Kadcyla), a lysine-linked antibody drug conjugate.
    Kim MT; Chen Y; Marhoul J; Jacobson F
    Bioconjug Chem; 2014 Jul; 25(7):1223-32. PubMed ID: 24873191
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Design, synthesis, and in vitro evaluation of dipeptide-based antibody minor groove binder conjugates.
    Jeffrey SC; Torgov MY; Andreyka JB; Boddington L; Cerveny CG; Denny WA; Gordon KA; Gustin D; Haugen J; Kline T; Nguyen MT; Senter PD
    J Med Chem; 2005 Mar; 48(5):1344-58. PubMed ID: 15743178
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Site-Specific
    Ahn SH; Vaughn BA; Solis WA; Lupher ML; Hallam TJ; Boros E
    Bioconjug Chem; 2020 Apr; 31(4):1177-1187. PubMed ID: 32138509
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In Vitro and In Vivo Evaluation of Cysteine Rebridged Trastuzumab-MMAE Antibody Drug Conjugates with Defined Drug-to-Antibody Ratios.
    Bryant P; Pabst M; Badescu G; Bird M; McDowell W; Jamieson E; Swierkosz J; Jurlewicz K; Tommasi R; Henseleit K; Sheng X; Camper N; Manin A; Kozakowska K; Peciak K; Laurine E; Grygorash R; Kyle A; Morris D; Parekh V; Abhilash A; Choi JW; Edwards J; Frigerio M; Baker MP; Godwin A
    Mol Pharm; 2015 Jun; 12(6):1872-9. PubMed ID: 25894424
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Statistics of the distribution of the abundance of molecules with various drug loads in maytansinoid antibody-drug conjugates.
    Goldmacher VS; Amphlett G; Wang L; Lazar AC
    Mol Pharm; 2015 Jun; 12(6):1738-44. PubMed ID: 25635630
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Advances in the study of site-specific antibody-drug conjugates].
    Sun Y; Huang R; Sun BW
    Yao Xue Xue Bao; 2015 Oct; 50(10):1225-31. PubMed ID: 26837166
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of Targets for Maytansinoid ADC Therapy Using a Novel Radiochemical Assay.
    Lai KC; Deckert J; Setiady YY; Shah P; Wang L; Chari R; Lambert JM
    Pharm Res; 2015 Nov; 32(11):3593-603. PubMed ID: 25630819
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chemical de-conjugation for investigating the stability of small molecule drugs in antibody-drug conjugates.
    Chen T; Su D; Gruenhagen J; Gu C; Li Y; Yehl P; Chetwyn NP; Medley CD
    J Pharm Biomed Anal; 2016 Jan; 117():304-10. PubMed ID: 26406314
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Site-specific glycan-conjugated NISTmAb antibody drug conjugate mimetics: synthesis, characterization, and utility.
    Agnew B; Lin S; Zhang T; Aggeler R; Mouchahoir T; Schiel J
    Anal Bioanal Chem; 2021 Aug; 413(20):4989-5001. PubMed ID: 34231000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.